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An 86-year-old male with chronic renal failure is referred to you for vascular access to allow dialysis. He has multiple
comorbidities including advanced dementia and terminal pancreatic cancer. The referring nephrologist, who has been one
of your biggest supporters, is apologetic but ﬁrm in his consultation for vascular access. The prominent family members,
who are substantial donors to the medical center, are insistent on Mr V. Ast getting treatment. In your professional
clinical ethical judgment, you strongly disagree. What should be done?A. Go along to get along.
B. Refuse outright.
C. Bring the matter before the ethics committee.
D. Schedule a meeting with the family.
E. Schedule a meeting with the nephrologist.I have learned from my life in medicine that death is
not always an enemy. Often it is good medical treatment.
Often it achieves what medicine cannot achievedit stops
suffering.dChristiaan Barnard (Good Life, Good Death)High-technology medicine’s cost is a continuing source
of ethical, policy, and political conﬂict recently brought to
the fore because of the coming tsunami of elderly Americans’
health problems. Medical technology’s attempt to counter
aging’s diseases is expensive and often only extends dying.
This dilemma was ﬁrst brought forth conceptually as the
“biomedicalization of aging” in 1989.1 Initiating medical
care, even complex costly care, became routine for serious
health problems without contemplation of what was being
accomplished. A trend towards evidence-based medicine
that uses outcomes data to assess critically indications for
diagnosis and treatment has been slow to gain traction.
A largely unrecognized genius, Dr Willem J. Kolff, a
Dutch physician, took a sausage skin and found that whenThe Center for Medical Ethics and Health Policy, Baylor College of
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the blood.2 Over the next several years, he developed a dial-
ysis machine, which he ﬁrst used in 1943. Of the ﬁrst 15 pa-
tients dialyzed, 14 died, but Dr Kolff persisted. The one
patient who survived had a urethral obstruction that was
corrected and did not need continued dialysis. At present,
there are over a million people worldwide being dialyzed.
Artiﬁcial support for organ failure began a half century
earlier with negative pressure mechanical ventilation,
dubbed “iron lungs” because of encasement of patients in
the machine. Ethical problems did not cling to the iron
lungs as they did to renal dialysis because iron lungs bridged
acute failure and dialysis was long term. Dialysis in America
was very limited in the 1960s, with machines available for
800 patients when 10,000 were qualiﬁed.2 “Death commit-
tees” considered who would receive treatment when a slot
became available from a death. One of us, as an intern, pre-
sented patients to such committees, usually successfully.
There are few more difﬁcult medical ethical problems
than establishing justice in allocating scarce medical
resources. The initial inadequate resources problem for
renal failure was solved in 1972 when the U.S. Congress
passed legislation establishing the Medicare End-Stage
Renal Disease Program, which began the following year.3
Medicare’s budget is generated by payroll taxes and pre-
miums paid by beneﬁciaries.
When unrestricted funding becomes available, scarcity
disappears. Nevertheless, the limitless funding concept is al-
ways an illusion when needs outreach resources, which is
about to take place as Baby Boomers reach chronic disease
age in the unhealthiest population on the planet.521
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speed ahead” phase in which death from disease was to be
delayed at all cost. That period was ushered out with the
futility concept.4 The futility concept sets common sense
limits on medical therapy as follows:
1. “Physiologic futility” is recognized when the inter-
vention is reliably expected not to produce its desired
physiologic effect. Cardiopulmonary resuscitation is
routinely discontinued when is in deliberative clinical
judgment it is not expected to restore spontaneous
circulation.
2. “Overall futility” reﬂects a reliable expectation that
the intervention will not restore the patient’s capacity
to interact with the environment and continue
human development.
3. “Imminent demise futility” characterizes a reliable
expectation that the patient will die before discharge
and not recover interactive capacity before death.
4. “Quality of life futility” applies when the patient’s
current or projected condition will result in an intol-
erable inability to engage in valued life tasks or to
derive sufﬁcient pleasure from doing so, understood
from the patient’s perspective.
In this case, initiating and providing dialysis will likely
not be physiologically futile. However, dialysis will involve
“overall futility” because the patient has lost interactive
capacity from advanced dementia. Dialysis will also
involve “quality of life futility” because the patient can
no longer engage in the life tasks that he once valued.
Dialysis will also set the patient on a direct course to
imminent demise futility. In professional clinical ethical
judgment, you are fully justiﬁed in disagreeing with the
request to provide vascular access for the purpose of start-
ing dialysis.
If you adopt optionA, you reduce yourself to the role of a
technician, someonewho is willing to perform procedures so
long as they are not anatomically or physiologically futile.
Surgeons who become mere technicians become predators
on, and not professional protectors of, their patients.
Outright refusal without discussing the matter with the
attending, option B, is not maintaining the professional
ethical role of a consultant. “The primary focus of the
surgeon’s concern should be on protecting and promoting
the patient’s health by fulﬁlling the consultant’s role in all
its aspects.”5 The major aspect of a consultant’s role is to
advise the attending responsible physician of an expert
opinion as to the optimum therapy, which in this caseshould aim for comfort and dignity in the clinical manage-
ment of multiple terminal conditions.
One of us (J.W.J.), soon after the Medicare End-Stage
Renal Disease Program began, when dialysis units sprang up
and the ﬂood gates opened for dialysis access, refused outright
a patient similar to Mr V. Ast and the reaction was rank. The
attending was so offended that he never sent another consult
and his friends and friends of friends followed suit. Consul-
tants shouldmaintain the professional integrity of their clinical
judgment and practice at all times, especiallywhen their short-
term economic interests are at stake.
There are situations where ethics committees’ opinions
are needed and are helpful in making decisions, but
differing opinions about therapy between physicians is
not one of them. Option C is not the answer.
“The [attending] internist is responsible for presenting
the patient with all of the medically reasonable alternatives
for managing his disease [not a consultant].”5
OptionE shouldbe implemented, followedbyOptionD.
The surgeon should meet with the nephrologist to
discuss the prognosis of overall or quality-of-life futility and
the unacceptable risk of putting the patient, unnecessarily,
on a path to imminent demise futility. The surgeon should
explain that surgery would not be in the patient’s best interest
and that a comfortable and digniﬁed death is the most
appropriate available goal. The surgeon should then offer to
join the referring physician in a family meeting to explain
why the professionally responsible management of Mr V.
Ast’s multiple medical problems precludes provision of
dialysis.
The message that needs to be conveyed, sensitively and
respectfully, is that extending an undesirable life situation is
trapping, by unwarranted technology, a person in a body
that nature is compassionately willing to allow an exit.Death is nature’s way of saying, your table’s ready.
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